Assessment of Total-Body Atherosclerosis by PET/Computed Tomography

PET Clin. 2021 Jan;16(1):119-128. doi: 10.1016/j.cpet.2020.09.013. Epub 2020 Nov 5.

Abstract

Atherosclerotic burden has become the focus of cardiovascular risk assessment. PET/computed tomography (CT) imaging with the tracers 18F-fluorodeoxyglucose and 18F-sodium fluoride shows arterial wall inflammation and microcalcification, respectively. Arterial uptake of both tracers is modestly age dependent. 18F-sodium fluoride uptake is consistently associated with risk factors and more easily measured in the heart. Because of extremely high sensitivity, ultrashort acquisition, and minimal radiation to the patient, total-body PET/CT provides unique opportunities for atherosclerosis imaging: disease screening and delayed and repeat imaging with global disease scoring and parametric imaging to better characterize the atherosclerosis of individual patients.

Keywords: Atherosclerosis; Calcification; FDG; Inflammation; NaF; PET/CT; Total body.

Publication types

  • Review

MeSH terms

  • Atherosclerosis / diagnostic imaging*
  • Humans
  • Positron Emission Tomography Computed Tomography / methods*
  • Whole Body Imaging / methods*